Quibim, a prominent player in precision imaging and artificial intelligence solutions, has launched QP-Breast® in Europe and the UK. This innovative AI tool, which has received CE and UKCA marking, is the first of its kind in these regions to utilize magnetic resonance imaging for the detection of breast cancer. By automatically identifying suspected lesions on breast MRI scans, QP-Breast® aims to enhance early diagnosis and improve patient outcomes. The launch, announced today, marks a significant advancement in breast cancer detection technology, reflecting Quibim's commitment to leveraging AI for better healthcare solutions.
Leave a comment